Trump threatens a 200% pharmaceutical tariff

US President Donald Trump appears near Defense Minister Pitt Hugset during a meeting with the White House Cabinet in Washington, Colombia, July 8, 2025.

Kevin Lamark | Reuters

President Donald Trump On Tuesday, he threatened to impose up to 200% of the tariffs on pharmaceuticals that were imported into the US “very quickly”.

“They will be tariffs at a very high rate like 200%,” Trump said during a cabinet meeting.

But he suggested that these levies would not come into force at once, saying that “would give people about a year and a half” “

“We will give them a certain period of time to gather our act,” Trump said, apparently referring to drug producers.

The president has repeatedly threatened and then changed the rate for tariff proposals, so there is no guarantee that he testifies to pharmaceutical tariffs at such a speed. After Trump’s commentary, he was largely unchanged.

This is Trump’s most significant commentary on pharmaceutical tariffs since April, when his administration has initiated the so -called section 232 of these products. This legal powers allows the commerce secretary to explore the impact of imports on national security.

These planned tariffs will strike a long -awaited stroke by pharmaceutical companies, many of which have pushed back and warned that fees could increase costs, hold back investment In the US and violation of the drug supply chain, at risk of patients. Industry is already moved by falling from Trump Pricing Policy for DrugsWhich drug manufacturers claim that both their lower lines and the ability to invest in research and development.

Trump said tariffs would stimulate drug addicts to move production operations in the US Eli Lily. Johnson and Johnson. Abbvie And others have already been investing more money in the US after the last few decades have decreased dramatically.

After Trump’s comments were largely unchanged pharmaceutical actions.

Source link